posted on 2023-03-31, 04:25authored byLauren A. Hapach, Shawn P. Carey, Samantha C. Schwager, Paul V. Taufalele, Wenjun Wang, Jenna A. Mosier, Nerymar Ortiz-Otero, Tanner J. McArdle, Zachary E. Goldblatt, Marsha C. Lampi, Francois Bordeleau, Jocelyn R. Marshall, Isaac M. Richardson, Jiahe Li, Michael R. King, Cynthia A. Reinhart-King
Supplemental data and methods
Funding
NCI
NIH
Vanderbilt Mouse Metabolic Phenotyping Center
National Institute of Diabetes and Digestive and Kidney Diseases
National Science Foundation-National Institutes of Health
National Science Foundation Graduate Research
Cancer Research Society
National Cancer Institute
History
ARTICLE ABSTRACT
Although intratumoral genomic heterogeneity can impede cancer research and treatment, less is known about the effects of phenotypic heterogeneities. To investigate the role of cell migration heterogeneities in metastasis, we phenotypically sorted metastatic breast cancer cells into two subpopulations based on migration ability. Although migration is typically considered to be associated with metastasis, when injected orthotopically in vivo, the weakly migratory subpopulation metastasized significantly more than the highly migratory subpopulation. To investigate the mechanism behind this observation, both subpopulations were assessed at each stage of the metastatic cascade, including dissemination from the primary tumor, survival in the circulation, extravasation, and colonization. Although both subpopulations performed each step successfully, weakly migratory cells presented as circulating tumor cell (CTC) clusters in the circulation, suggesting clustering as one potential mechanism behind the increased metastasis of weakly migratory cells. RNA sequencing revealed weakly migratory subpopulations to be more epithelial and highly migratory subpopulations to be more mesenchymal. Depletion of E-cadherin expression from weakly migratory cells abrogated metastasis. Conversely, induction of E-cadherin expression in highly migratory cells increased metastasis. Clinical patient data and blood samples showed that CTC clustering and E-cadherin expression are both associated with worsened patient outcome. This study demonstrates that deconvolving phenotypic heterogeneities can reveal fundamental insights into metastatic progression. More specifically, these results indicate that migratory ability does not necessarily correlate with metastatic potential and that E-cadherin promotes metastasis in phenotypically sorted breast cancer cell subpopulations by enabling CTC clustering.
This study employs phenotypic cell sorting for migration to reveal a weakly migratory, highly metastatic breast cancer cell subpopulation regulated by E-cadherin, highlighting the dichotomy between cancer cell migration and metastasis.